BioXcel Therapeutics Inc (BTAI)
2.97
+0.12
(+4.21%)
USD |
NASDAQ |
Apr 23, 16:00
2.92
-0.05
(-1.68%)
After-Hours: 20:00
BioXcel Therapeutics Cash from Investing (TTM): -0.02M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.02M |
| September 30, 2023 | -0.02M |
| June 30, 2023 | -0.02M |
| March 31, 2023 | -0.019M |
| December 31, 2022 | -0.139M |
| September 30, 2022 | -0.151M |
| June 30, 2022 | -0.168M |
| March 31, 2022 | -0.249M |
| December 31, 2021 | -0.445M |
| September 30, 2021 | -0.703M |
| June 30, 2021 | -0.681M |
| March 31, 2021 | -0.616M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.316M |
| September 30, 2020 | -0.048M |
| June 30, 2020 | -0.096M |
| March 31, 2020 | -0.286M |
| December 31, 2019 | -0.87M |
| September 30, 2019 | -1.026M |
| June 30, 2019 | -1.045M |
| March 31, 2019 | -0.94M |
| December 31, 2018 | -0.34M |
| September 30, 2018 | -0.182M |
| June 30, 2018 | -0.12M |
| March 31, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.045M
Minimum
Jun 2019
-0.019M
Maximum
Mar 2023
-0.3641M
Average
-0.249M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Synlogic Inc | 38.77M |
| Cormedix Inc | -17.06M |
| Bristol-Myers Squibb Co | -2.295B |
| Verastem Inc | -44.45M |
| Ocular Therapeutix Inc | -6.087M |